Circe Biomedical
Lexington
About Circe Biomedical
Circe Biomedical, Inc. develops, produces, and commercializes bioartificial organ systems. It develops bioartificial organs from isolated mammalian cells and membranes for patients suffering from acute, end-stage liver failure. The company also develops PancreAssist System, an implantable, bioartificial pancreas for severe insulin-dependent diabetics. Circe Biomedical, Inc. was incorporated in 1999 and is based in Lexington, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.0M
- Funding stage: Private Equity
- Last round: Private Equity (Dec 2000)
- Website: circebio.com
- Phone: (617)863-8720
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/circe-biomedical-3664914 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.